Cargando…

Frequency and Predictors of Relapses following SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis: Interim Results from a Longitudinal Observational Study

Despite protection from severe COVID-19 courses through vaccinations, some people with multiple sclerosis (PwMS) are vaccination-hesitant due to fear of post-vaccination side effects/increased disease activity. The aim was to reveal the frequency and predictors of post-SARS-CoV-2-vaccination relapse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frahm, Niklas, Fneish, Firas, Ellenberger, David, Haas, Judith, Löbermann, Micha, Peters, Melanie, Pöhlau, Dieter, Röper, Anna-Lena, Schilling, Sarah, Stahmann, Alexander, Temmes, Herbert, Paul, Friedemann, Zettl, Uwe Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254005/ https://www.ncbi.nlm.nih.gov/pubmed/37297838 http://dx.doi.org/10.3390/jcm12113640

Ejemplares similares

SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational study
por: Frahm, Niklas, et al.
Publicado: (2022)

Relapsing and progressive MS: the sex-specific perspective
por: Rommer, Paulus Stefan, et al.
Publicado: (2020)

Aggressive multiple sclerosis: a matter of measurement and timing
por: Ellenberger, David, et al.
Publicado: (2020)

Application of Statistical Methods for Central Statistical Monitoring and Implementations on the German Multiple Sclerosis Registry
por: Fneish, Firas, et al.
Publicado: (2023)

Therapy Switches in Fingolimod-Treated Patients with Multiple Sclerosis: Long-Term Experience from the German MS Registry
por: Frahm, Niklas, et al.
Publicado: (2022)

Management of MS Patients Treated With Daclizumab – a Case Series of 267 Patients
por: Rommer, Paulus S., et al.
Publicado: (2020)

Treatment patterns in pediatric patients with multiple sclerosis in Germany—a nationwide claim-based analysis
por: Frahm, Niklas, et al.
Publicado: (2021)

Polypharmacy in outpatients with relapsing-remitting multiple sclerosis: A single-center study
por: Frahm, Niklas, et al.
Publicado: (2019)

Epileptic seizures at multiple sclerosis onset and their role in disease progression
por: Grothe, Matthias, et al.
Publicado: (2023)

Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registry
por: Ohle, Lisa-Marie, et al.
Publicado: (2021)

Effect of applying inclusion and exclusion criteria of phase III clinical trials to multiple sclerosis patients in routine clinical care
por: Jalusic, Kris Oliver, et al.
Publicado: (2021)

Multi-drug use among patients with multiple sclerosis: A cross-sectional study of associations to clinicodemographic factors
por: Frahm, Niklas, et al.
Publicado: (2019)

Polypharmacy in patients with multiple sclerosis: a gender-specific analysis
por: Frahm, Niklas, et al.
Publicado: (2019)

Die Corona-Pandemie und Multiple Sklerose: Impfungen und deren Implikationen für Patienten – Teil 1: Empfehlungen
por: Monschein, Tobias, et al.
Publicado: (2021)

Die Corona-Pandemie und Multiple Sklerose: Impfungen und deren Implikationen für Patienten – Teil 2: Impfstofftechnologien
por: Monschein, Tobias, et al.
Publicado: (2021)

Vaccination in multiple sclerosis patients treated with highly effective disease-modifying drugs: an overview with consideration of cladribine tablets
por: Gold, Ralf, et al.
Publicado: (2021)

Improving Risk Assessment in Clinical Trials: Toward a Systematic Risk-Based Monitoring Approach
por: Fneish, Firas, et al.
Publicado: (2021)

Patient satisfaction following transition from the original to the new formulation of subcutaneous interferon beta-1a in relapsing multiple sclerosis: a randomized, two-arm, open-label, Phase IIIb study
por: Camu, William, et al.
Publicado: (2010)

The risk of polypharmacy, comorbidities and drug–drug interactions in women of childbearing age with multiple sclerosis
por: Frahm, Niklas, et al.
Publicado: (2020)

Patient Benefit of Clinical Research in Diversely Advanced African Developing Countries
por: Strüver, Vanessa, et al.
Publicado: (2021)

Vaccination Coverage against Tetanus, Diphtheria, Pertussis and Poliomyelitis and Validity of Self-Reported Vaccination Status in Patients with Multiple Sclerosis
por: Langhorst, Silvan Elias, et al.
Publicado: (2022)

Side effects following vaccination in multiple sclerosis: a prospective, multi-centre cohort study
por: Winkelmann, Alexander, et al.
Publicado: (2023)

Vaccination willingness in association with personality traits in patients with multiple sclerosis in the course of SARS-CoV-2 pandemic
por: Heidler, Felicita, et al.
Publicado: (2022)

Posttraumatic Aneurysm of a Patent Umbilical Vein: Diagnosis and Specific Treatment
por: Grade, Matthias, et al.
Publicado: (2017)

Comparison of employment among people with Multiple Sclerosis across Europe
por: Ellenberger, David, et al.
Publicado: (2022)

Rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis
por: Zrzavy, Tobias, et al.
Publicado: (2021)

Vaccination and immunotherapies in neuroimmunological diseases
por: Winkelmann, Alexander, et al.
Publicado: (2022)

Prevalence and Severity of Potential Drug–Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy
por: Bachmann, Paula, et al.
Publicado: (2022)

Associated factors of potential drug-drug interactions and drug–food interactions in patients with multiple sclerosis
por: Debus, Jane Louisa, et al.
Publicado: (2022)

Interim Report
por: SSC. Central Design Group. USA
Publicado: (1985)

Tickborne Meningoencephalitis, First Case after 19 Years in Northeastern Germany
por: Hemmer, Christoph J., et al.
Publicado: (2005)

Therapy of women with multiple sclerosis: an analysis of the use of drugs that may have adverse effects on the unborn child in the event of (unplanned) pregnancy
por: Haker, Marie-Celine, et al.
Publicado: (2023)

Depression and Anxiety in Association with Polypharmacy in Patients with Multiple Sclerosis
por: Baldt, Julia, et al.
Publicado: (2023)

Quality of life and life circumstances in German myasthenia gravis patients
por: Twork, Sabine, et al.
Publicado: (2010)

Tick-borne encephalitis vaccination in multiple sclerosis: A prospective, multicenter study
por: Winkelmann, Alexander, et al.
Publicado: (2019)

Piper crocatum Ruiz & Pav. ameliorates wound healing through p53, E-cadherin and SOD1 pathways on wounded hyperglycemia fibroblasts
por: Setyawati, Andina, et al.
Publicado: (2021)

Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases
por: Hecker, Michael, et al.
Publicado: (2022)

Fourth Interim Report
por: Y. Blumenfeld and John Cornell
Publicado: (26/1)

Interim Design Report
por: Choubey, S., et al.
Publicado: (2011)

Structures - Interim Note
por: Sicard, C H
Publicado: (1983)

Cannot write session to /tmp/vufind_sessions/sess_0lm4nj6cl5rpf0l0666pv99f55